The pharmaceutical industry is likely to benefit from climate change as increasing temperatures are expected to result in a rise in the number of diseases spread by vectors, such as mosquitoes and fleas, thereby increasing demand for vaccines, according to a report from Morgan Stanley . The report singled out the mosquitoes Aedes aegypti and Morgan Stanley albopictus in particular and predicted earth as the most affected region. A report released by Morgan Stanley predicts that the pharmaceutical industry will benefit from a warming planet, as the spread of disease will become more prevalent, revealing opportunities for medicine markets. The report estimated that $ 125bn to $ 50bn of vaccines will be needed to cover the extra exposure, with today and GlaxoSmithKline set to benefit the most due to their pipelines for tropical disease drugs.
The pharmaceutical industry is likely to benefit from climate change as increasing temperatures are expected to result in a rise in the number of diseases spread by vectors, such as mosquitoes and fleas, thereby increasing demand for vaccines, according to a report from Morgan Stanley . The report singled out the mosquitoes Aedes aegypti and Morgan Stanley albopictus in particular and predicted earth as the most affected region. The report estimated that $ 125bn to $ 50bn of vaccines will be needed to cover the extra exposure, with today and GlaxoSmithKline set to benefit the most due to their pipelines for tropical disease drugs.